The effect of sCD4 on the binding and accessibility of HIV-1 gp41 MPER epitopes to human monoclonal antibodies (Q85228912)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961591%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

The effect of sCD4 on the binding and accessibility of HIV-1 gp41 MPER epitopes to human monoclonal antibodies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961591%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

3

Victoria R Polonis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961591%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Kristina K Peachman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961591%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Lindsay Wieczorek

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961591%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Carl R Alving

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961591%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Mangala Rao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961591%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

20 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961591%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961591%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

408

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961591%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961591%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

213-223

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961591%20AND%20SRC:MED&resulttype=core&format=json

Role of HIV membrane in neutralization by two broadly neutralizing antibodies

15 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Redox-Triggered Infection by Disulfide-Shackled Human Immunodeficiency Virus Type 1 Pseudovirions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: role of phosphate-binding subsites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

HIV vaccine design and the neutralizing antibody problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Antibody vs. HIV in a clash of evolutionary titans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Structural basis for coreceptor selectivity by the HIV type 1 V3 loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

HIV entry and its inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

The structural biology of type I viral membrane fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Binding of the 2F5 monoclonal antibody to native and fusion-intermediate forms of human immunodeficiency virus type 1 gp41: implications for fusion-inducing conformational changes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Generation of human monoclonal antibodies to human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

7 January 2021

Viral membrane fusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Structure of a V3-containing HIV-1 gp120 core

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

HIV-1 envelope pseudotyped viral vectors and infectious molecular clones expressing the same envelope glycoprotein have a similar neutralization phenotype, but culture in peripheral blood mononuclear cells is associated with decreased neutralization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Effect of soluble CD4 on exposure of epitopes on primary, intact, native human immunodeficiency virus type 1 virions of different genetic clades

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

A virus binding assay for studying the antigenic landscape on intact, native, primary human immunodeficiency virus-type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Evaluation of aldrithiol-2-inactivated preparations of HIV type 1 subtypes A, B, and D as reagents to monitor T cell responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Specific phospholipid recognition by human immunodeficiency virus type-1 neutralizing anti-gp41 2F5 antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Crystal structures of human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Soluble CD4 broadens neutralization of V3-directed monoclonal antibodies and guinea pig vaccine sera against HIV-1 subtype B and C reference viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Interactions between Lipids and Human Anti-HIV Antibody 4E10 Can Be Reduced without Ablating Neutralizing Activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Structural definition of a conserved neutralization epitope on HIV-1 gp120

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Identifying epitopes of HIV-1 that induce protective antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

inferred from DOI database lookup

7 January 2021

based on heuristic

Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.09.029

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2010.09.029

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961591%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference